The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.

Should an energy drink with more caffeine than five cans of soda be marketed to kids? Sen. Chunk Schumer shared his concerns in a new letter to FDA Commissioner Robert Califf, MD, a veteran cardiologist. 

Researchers tracked data from nearly 38,000 obese patients who underwent TAVR or SAVR, sharing their findings in a new meta-analysis. 

The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin. 

A team of specialists from the Cleveland Clinic detailed the potential benefits—and risks—associated with following a ketogenic diet to address heart failure symptoms. The group recommended borrowing heavily from the Mediterranean diet and avoiding heavily processed "keto-friendly" products. 

The three-year grant will help the ADA fund two pilot programs and engage with healthcare professionals and other industry leaders.